Market Overview:

The organ preservation market is experiencing rapid growth, driven by advancements in preservation technologies, rising demand for organ transplants, and supportive government and ngo initiatives. According to IMARC Group's latest research publication, "Organ Preservation Market Report by Preservation Solution (UW Solution, Custodiol HTK, Perfadex, and Others), Organ Donation Type (Living Organ Donation, Deceased Organ Donation), Technique (Static Cold Storage Technique, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidney, Liver, Lung, Heart, and Others), End-User (Hospitals and Clinics, Organ Banks, and Others), and Region 2025-2033", The global organ preservation market size was valued at USD 198.87 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 320.40 Million by 2033, exhibiting a CAGR of 5.39% from 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Grab a sample PDF of this report: https://www.imarcgroup.com/organ-preservation-market/requestsample

Our report includes: 

• Market Dynamics
• Market Trends And Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Organ Preservation Market

• Advancements in Preservation Technologies:

The organ preservation market is experiencing significant growth due to continuous innovations in preservation technologies. Advanced solutions, such as hypothermic machine perfusion and normothermic preservation, have improved the ability to maintain organ viability outside the body. For example, devices like the OrganOx metra system keep livers functional for up to 24 hours by mimicking the body’s natural environment. These technologies reduce organ damage during transport, increasing transplant success rates. Additionally, research into cryopreservation techniques is pushing boundaries, with institutions like the University of Minnesota exploring methods to freeze and thaw organs without cellular damage. Such advancements are expanding the pool of viable organs, addressing global shortages and driving market growth.

• Rising Demand for Organ Transplants:

The increasing prevalence of chronic diseases, such as kidney and liver failure, is fueling demand for organ transplants, thereby boosting the organ preservation market. For instance, the National Kidney Foundation reports millions of patients worldwide await kidney transplants due to rising diabetes and hypertension cases. This growing need has spurred investments in preservation solutions to ensure organs remain viable during longer transport times. Case studies, like those from the United Network for Organ Sharing (UNOS), show that improved preservation techniques have enabled cross-country organ sharing, saving lives. As transplant waitlists grow, the need for reliable preservation methods continues to drive market expansion and innovation.

• Supportive Government and NGO Initiatives:

Government and non-governmental organizations are playing a pivotal role in market growth by funding research and raising awareness about organ donation. Programs like the U.S. Department of Health and Human Services’ Organ Procurement and Transplantation Network support the development of preservation technologies to improve transplant outcomes. Similarly, NGOs like the Gift of Life Donor Program collaborate with hospitals to streamline organ procurement and preservation processes. These initiatives ensure better access to preservation solutions, particularly in developing regions where infrastructure is limited. By fostering public-private partnerships and funding clinical trials, such efforts are enhancing preservation capabilities and expanding the market globally.

Key Trends in the Organ Preservation Market

• Adoption of Machine Perfusion Systems:

Machine perfusion systems are becoming a dominant trend in organ preservation, replacing traditional static cold storage. These systems, such as the LifePort Kidney Transporter, actively pump oxygenated solutions through organs, maintaining their function during transport. This trend is driven by evidence showing perfusion systems improve transplant outcomes, particularly for marginal organs. For example, a 2023 study in the New England Journal of Medicine demonstrated that machine-perfused kidneys had better post-transplant function compared to those stored in cold storage. As hospitals and transplant centers increasingly adopt these systems, the market is seeing a shift toward more sophisticated, outcome-driven preservation solutions.

• Focus on Personalized Preservation Solutions:

The organ preservation market is witnessing a trend toward personalized preservation techniques tailored to specific organs and patient needs. Researchers are developing solutions that account for organ type, donor characteristics, and recipient conditions. For instance, companies like XVIVO Perfusion are creating specialized perfusion fluids for lungs, which differ from those used for hearts or livers. This customization improves organ quality and transplant success. A case study from the Cleveland Clinic showed that tailored preservation protocols for heart transplants reduced rejection rates by 15%. As precision medicine gains traction, this trend is expected to drive innovation and market growth.

• Expansion of Organ Preservation in Emerging Markets:

Emerging markets, particularly in Asia and Latin America, are becoming key players in the organ preservation market due to improving healthcare infrastructure and rising transplant programs. Countries like India and Brazil are investing in transplant centers, increasing the demand for preservation solutions. For example, India’s Apollo Hospitals have expanded their transplant programs, incorporating advanced preservation technologies to support growing demand. This trend is supported by local governments easing regulations and promoting organ donation awareness. As these regions address organ shortages and improve access to preservation technologies, the global market is experiencing significant growth, with new opportunities for manufacturers and healthcare providers.

Leading Companies Operating in the Global Organ Preservation Industry:

• 21st Century Medicine
• Biolife Solutions
• Bridge to Life Ltd.
• Bristol-Myers Squibb
• Dr. Franz Köhler Chemie GmbH
• Essential Pharmaceuticals.
• Lifeline Scientific
• OrganOx
• Paragonix Technologies
• TransMedics, Waters Medical Systems
• Xvivo Perfusion

Organ Preservation Market Report Segmentation:   

By Preservation Solution: 

• UW Solution
• Custodiol HTK
• Perfadex
• Others

UW solution represents the largest segment due to its exceptional ability to preserve organs during transplantation procedures.

By Organ Donation Type:

• Living Organ Donation
• Deceased Organ Donation 

Deceased organ donation represents the largest segment, as it allows for UW solution exhibits a clear dominance in the market due to its comprehensive ability to reduce cellular swelling and preserve multiple organ types.

By Technique:

• Static Cold Storage Technique
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion
• Others 

Static cold storage technique holds the biggest market share attributed to its simplicity and cost-effectiveness in preserving organs.

By Organ Type:

• Kidney
• Liver
• Lung
• Heart
• Others 

Kidney dominates the market, driven by their higher demand and frequency of transplants.

By End-User:

• Hospitals and Clinics
• Organ Banks
• Others

Organ banks account for the majority of the market share accredited to their pivotal role in managing organ donations, storage, and distribution efficiently.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America dominates the market owing to the presence of an advanced healthcare infrastructure and a high rate of organ donation and transplantation activities.

Research Methodology:

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145